Board modifies drug monitoring regulation after health systems, doctors request changes
The Controlled Substances Board modified rules regarding the use of the Prescription Drug Monitoring Program to align with a recently approved change to the state budget, but rejected other proposals from health systems and doctors.
To access this content, you must purchase a Premium membership, or log in if you are a member.
